Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MDGL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
MDGL
Madrigal Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MDGL
8
PFE
Pfizer
supplier
—
Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)
unlisted
supplier
—
Roche
unlisted
supplier
—
Cowen
unlisted
supplier
4 more · MDGL chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
MDGL
Madrigal Pharmaceuticals, Inc.
Change
456.60
▲
+5.90%
Mkt cap
$9.9B
Revenue
$431M
Q3 FY26
Revenue
$958M
FY25
LLY
ELI Lilly & Co
Change
1,419.04
▲
+0.57%
Regular session
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 3 '26
MDGL
Madrigal Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
456.60
▲
+5.90%
Price
1,419.04
▲
+0.57%
$9.9B
Mkt cap
$1.3T
Q3 FY26
$431M
Revenue
$24.4B
Q3 FY26
FY25
$958M
Revenue
$65.2B
FY25
Change
Change
MDGL
456.60
▲
+5.90%
vs
LLY
1,419.04
▲
+0.57%
Regular session
Nov 3 '26